Methylenedioxycathinone

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Methylenedioxycathinone
MDC.png
Clinical data
Routes of
administration
Oral, Insufflation, Rectal
ATC code
  • none
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C10H11NO3
Molar mass 193.20 g·mol−1
3D model (Jmol)
  (verify)

3,4-Methylenedioxycathinone (also known as MDC, Nitrilone, Amylone and βk-MDA) is an empathogen and stimulant of the phenethylamine, amphetamine, and cathinone classes[1][2] and the β-keto analogue of MDA.[3]

Methylenedioxycathinone has been investigated as antidepressant and antiparkinson agent.[4]

See also[edit]

References[edit]

  1. ^ Kei Zaitsu; Munehiro Katagi; Michiaki Tatsuno; Takako Sato; Hitoshi Tsuchihashi; Koichi Suzuki (July 2011). "Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis". Forensic Toxicology. 29 (2): 73–84. doi:10.1007/s11419-011-0111-8. 
  2. ^ Terry A Dal Cason; Richard Young; Richard A Glennon (December 1997). "Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs". Pharmacology Biochemistry and Behavior. 58 (4): 1109–1116. doi:10.1016/S0091-3057(97)00323-7. PMID 9408221. 
  3. ^ Terry A Dal Cason (May 1997). "The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs". Forensic Science International. 87 (1): 9–53. doi:10.1016/S0379-0738(97)02133-6. 
  4. ^ Peyton Jacob Iii; Alexander T Shulgin (12 December 1996). "Patent Application WO 1996039133 - Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents.". Retrieved 13 October 2015.